French Polynesia repeals its law on medical cannabis
The Assembly of French Polynesia recently voted to repeal the law of January 5, 2023, which aimed to pave the way for the legalization of medical cannabis. The decision, prompted by the complexity of implementing the original law, sparked debate among the archipelago's various political currents. Nevertheless, it should pave the way for a new, more rational and effective framework for medical cannabis in the region.
Repeal to legalize
Political game or real necessity? In any case, the assembly session focused on repealing the law of January 5, 2023, which initiated the legalization of the medical use of cannabis in Polynesia, but was deemed too complex to be implemented in time. It required numerous deliberations and decrees. And the absence of implementing regulations in the initial law rendered it null and void 1 year after its vote, hence the repeal.
TNTV reported that repeal was a controversial issue, with the Tavini and A'Here ia Porinetia majority voting against the law described as a «gas factory» by Moetai Brotherson. The complications of the original law were acknowledged by unaffiliated representatives, including Nicole Sanquer, who stressed the importance of depoliticizing the process.
Despite expressing skepticism about the government's motives, Ms. Sanquer voted in favor of repeal, emphasizing the urgent need to address the reality of therapeutic cannabis use in the country. She stressed the need for a more effective and targeted approach, echoing the feeling that the previous attempt had been more about electoral strategy than practical governance.
Medical cannabis and hemp
Moetai Brotherson's government will now have to draw up a new text that will simplify the eligibility process, include traditional practitioners among those authorized to distribute therapeutic cannabis and authorize the import of cannabis-based medicines. The Minister of Health, Cedric Mercadal, has assured that the new draft text will be submitted before the end of December, with a presentation to the Assembly scheduled for January.
The government also needs to legislate on the establishment of a hemp industry, a challenge compounded by the fact that studies in progress at Institut Louis Malardé on the census of local cannabis varieties. The future text on hemp could be aligned with metropolitan France and its maximum THC threshold for plants and products derived from them, i.e. less than 0.3 % THC.
This strategic approach is designed to facilitate implementation and address concerns about the unregulated use of cannabis products. Local associations Nevertheless, the 1% THC level is a good choice. in the plant by virtue of the climate, which is highly conducive to the development of cannabinoids in hemp.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login